Retrospective analysis of opioid medication incidents requiring administration of naloxone

Canadian Journal of Hospital Pharmacy

Volumn 66, Issue 5, 2013, Pages 280-288

  Neil, Katherine ^a   Marcil, Allison ^a   Kosar, Lynette ^a   Dumont, Zack ^a   Ruda, Lisa ^a   McMillan, Kaitlyn ^a  

^a REGINA QU APPELLE HEALTH REGION   (Canada)

Author keywords

Medication incident; Medication safety; Naloxone; Opioid

Indexed keywords

CODEINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PETHIDINE;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; BREAKTHROUGH PAIN; CHILD; CONTINUOUS INFUSION; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; EMERGENCY CARE; EMERGENCY PATIENT; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MIDDLE AGED; PRESCHOOL CHILD; PRESCRIPTION; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SELF REPORT; THEMATIC ANALYSIS; YOUNG ADULT;

EID: 84902202075     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v66i5.1284     Document Type: Article

References (31)

1. Jha AK, Prasopa-Plaizier N, Larizgoitia I, Bates DW. Patient safety research: an overview of the global evidence. Qual Saf Health Care. 2010;19(1):42-7
2. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004;170(11):1678-86 (Pubitemid 38758745)
3. Strausberg J, Hasford J. Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data. BMC Health Serv Res. 2011;11:134
4. Dequito AB, Mol PG, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM, et al. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands. Drug Saf. 2011;34(11):1089-100
5. Definitions of terms. Toronto (ON): Institute for Safe Medication Practices Canada; 2012 [cited 2012 Apr 25]. Available from: www.ismp-canada.org/ definitions.htm
6. Davis NM, Cohen MR. Today's poisons: how to keep them from killing your patients. Nursing. 1989;19(1):49-51
7. Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007;41(3):400-6
8. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266(20):2847-51
9. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274(1):29-34
10. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm. 2003;60(17):1750-9 (Pubitemid 44717415)
11. Ongoing, preventable fatal events with fentanyl transdermal patches are alarming! ISMP Med Saf Alert. 2007 [cited 2012 Dec 23];12(13):1-3. Available from: www.ismp.org/newsletters/acutecare/articles/20070628.asp
12. Hydromorphone intended for an adult patient inadvertently administered to an infant. ISMP Can Saf Bull. 2008 [cited 2012 Dec 23];8(6):1-3. Available from: http://ismp-canada.org/download/safetyBulletins/ISMPCSB2008- 06Hydromorphone.pdf
13. Top 10 drugs reported as causing harm through medication error. ISMP Can Saf Bull. 2006 [cited 2012 Dec 23];6(1):1-2. Available from: www.ismpcanada. org/download/safetyBulletins/ISMPCSB2006-01Top10.pdf
14. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194-200 (Pubitemid 36723946)
15. Whipple JK, Ausman RK, Quebbeman EJ. Narcotic use in the hospital: reasonably safe? Ann Pharmacother. 1992;26(7-9):897-901
16. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, et al. Systematic review of medication safety assessment methods. Am J Health Syst Pharm. 2011;68(3):227-40
17. Whipple JK, Quebbeman EJ, Lewis KS, Gottlieb MS, Ausman RK. Difficulties in diagnosing narcotic overdoses in hospitalized patients. Ann Pharmacother. 1994;28(4):446-50 (Pubitemid 24123754)
18. Tam KW, Kwok KH, Fan YM, Tsui KB, Ng KK, Ho KY, et al. Detection and prevention of medication misadventures in general practice. Int J Qual Health Care. 2008;20(3):192-9 (Pubitemid 351753558)
19. Cornish P, Etchells E, Kahan M, Salsman B, Sawyer J, Senders J. Shared learning - reported incidents involving hydromorphone. ISMP Can Saf Bull. 2006;6(9):1-3. Available from: www.ismp-canada.org/download/safety Bulletins/ISMPCSB2006-09Hydromorphone.pdf
20. McDonnell C. Opioid medication errors in pediatric practice: four years' experience of voluntary safety reporting. Pain Res Manage. 2011;16(2):93-8
21. Taylor JA, Brownstein D, Christakis DA, Blackburn S, Strandjord TP, Klein EJ, et al. Use of incident reports by physicians and nurses to document medical errors in pediatric patients. Pediatrics. 2004;114(3):729-35 (Pubitemid 41529531)
22. Greenall J, Senders JW. Medication safety alerts. Root cause analysis: learning from adverse events and near misses. Can J Hosp Pharm. 2006;59(1):34-6
23. Extended-release (ER) and long-acting (LA) opioid analgesics risk evaluation and mitigation strategy (REMS). Silver Spring (MD): US Food and Drug Administration; 2012 [cited 2012 Aug 28]. Available from: www.fda.gov/ downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor PatientsandProviders/UCM311290.pdf
24. Analysis of international findings from incidents involving fentanyl transdermal patches. ISMP Can Saf Bull. 2009 [cited 2012 Dec 23];9(10):1-2. Available from: http://ismp-canada.org/download/safetyBulletins/ISMPCSB2009- 10-AnalysisOfInternationalFindingsFromIncidentsInvolvingFentanyl Transdermal.pdf
25. Cheng R, Samples C, U D, Hyland S, Ho C. Fentanyl patches: analysis of international medication incidents [abstract]. Can J Hosp Pharm. 2010;63(4):342
26. Fentanyl patch linked to another death in Canada. ISMP Can Saf Bull. 2007 [cited 2012 Dec 23];7(5):1-2. Available from: www.ismp-canada.org/ download/safetyBulletins/ISMPCSB2007-05Fentanyl.pdf
27. Methadone: not your typical narcotic! ISMP Can Saf Bull. 2003 [cited 2012 Dec 23];3(12):1-2. Available from: http://ismp-canada.org/download/ safetyBulletins/ISMPCSB2003-12Methadone.pdf
28. Keeping patients safe from iatrogenic methadone overdoses. ISMP Med Saf Alert. 2008 [cited 2012 Dec 23];13(3):1-3. Available from: https:// www.ismp.org/newsletters/acutecare/articles/20080214.asp
29. Evans SM, Smith BJ, Esterman A, Runciman WB, Madderm G, Stead K, et al. Evaluation of an intervention aimed at improving voluntary incident reporting in hospitals. Qual Saf Health Care. 2007;16(3):169-75 (Pubitemid 46972858)
30. Katz R, Lagasse RS. Factors influencing the reporting of adverse perioperative outcomes to a quality management program. Anasth Analg. 2000;90(2): 344-50 (Pubitemid 30078013)
31. Medication safety officer sample job description. Bethesda (MD): American Society of Health-System Pharmacists; 2012 [cited 2012 May 17]. Available from: www.ashp.org/DocLibrary/Policy/PatientSafety/Sample- Job-Description-1.aspx